# Surgical Oncology * **Definition:** A specialized field of surgery that focuses on the surgical management and treatment of cancer, involving procedures to remove tumors and surrounding tissue, often in conjunction with other cancer therapies. * **Taxonomy:** Specialties / Surgical Oncology ## News * Selected news on the topic of **Surgical Oncology**, for healthcare technology leaders * 9.3K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 2/5/2025 | [**Enhancing Completeness in Pediatric Surgical Oncology Reports**](https://www.physiciansweekly.com/enhancing-completeness-in-pediatric-surgical-oncology-reports/) | [[Physicians Weekly]] | | 12/26/2024 | [**The Inner Circle acknowledges, Ayana Allard-Picou, MD, FACS, FSSO as a Pinnacle Lifetime Member**](https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-ayana-allard-picou-md-facs-fsso-as-a-pinnacle-lifetime-member-302339360.html) | [[PR Newswire]] | | 12/26/2024 | [**The Inner Circle acknowledges, Ayana Allard-Picou, MD, FACS, FSSO as a Pinnacle Lifetime Member**](https://finance.yahoo.com/news/inner-circle-acknowledges-ayana-allard-200700004.html) | [[Yahoo Finance]] | | 12/26/2024 | [**Cosmos Health Appoints Dimitrios Trafalis as Head of Oncology - FirstWord Pharma**](https://firstwordpharma.com/story/5923956) | [[FirstWord PHARMA]] | | 12/12/2024 | [**Health IT Business News - December 12, 2024**](https://www.healthitanswers.net/health-it-business-news-december-12-2024/) | [[Health IT Answers]] | | 12/10/2024 | [**Beghou Consulting Adds Three Partners to Strengthen Data and Analytics Excellence and Commercialization Expertise Across Emerging Life Sciences Sectors**](https://www.prweb.com/releases/beghou-consulting-adds-three-partners-to-strengthen-data-and-analytics-excellence-and-commercialization-expertise-across-emerging-life-sciences-sectors-302326336.html) | [[PRWeb]] | | 11/15/2024 | [**Whole Genome and Exome Sequencing Markets, 2033 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241115785002/en/Whole-Genome-and-Exome-Sequencing-Markets-2033---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/1/2024 | [**Xtalks Announces its Life Science Webinar Calendar for November 2024**](https://www.prweb.com/releases/xtalks-announces-its-life-science-webinar-calendar-for-november-2024-302293808.html) | [[PRWeb]] | | 11/1/2024 | [**Ferrum Health Raises $16M in Series A Funding to Unlock AI Adoption in Healthcare**](https://www.healthcareittoday.com/2024/11/01/ferrum-health-raises-16m-in-series-a-funding-to-unlock-ai-adoption-in-healthcare/) | [[Healthcare IT Today]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics ...**](https://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals) | [[Business Wire]] | | 10/29/2024 | [**Asia-Pacific Digital Diagnostics Market Analysis and Forecast, 2023-2024 & 2033: Synergetic Partnership Opportunities with Hospitals and Diagnostic Centers Fuel Opportunities - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241029232642/en/Asia-Pacific-Digital-Diagnostics-Market-Analysis-and-Forecast-2023-2024-2033-Synergetic-Partnership-Opportunities-with-Hospitals-and-Diagnostic-Centers-Fuel-Opportunities---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics' Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals**](http://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/22/2024 | [**HLTH: Avandra Launches World's Largest Federated Network for Medical Imaging and Clinical Data**](https://hitconsultant.net/2024/10/22/avandra-launches-worlds-largest-federated-network-for-medical-imaging-and-clinical-data/) | [[HIT Consultant]] | | 10/16/2024 | [**FDA strengthens AI regulation to ensure patient safety and innovation in healthcare**](https://www.news-medical.net/news/20241016/FDA-strengthens-AI-regulation-to-ensure-patient-safety-and-innovation-in-healthcare.aspx) | [[News Medical Net]] | | 10/9/2024 | [**Look Who's Talking at HLTH - MedCity News**](https://medcitynews.com/2024/10/look-whos-talking-at-hlth/) | [[MedCity News]] | | 10/4/2024 | [**Hyper-Personalized Medicine Market Research 2024: Size, Trends, Opportunities and Forecast 2020-2024 & 2025-2030 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241004930872/en/Hyper-Personalized-Medicine-Market-Research-2024-Size-Trends-Opportunities-and-Forecast-2020-2024-2025-2030---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/23/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823929) | [[JAMA Network]] | | 9/4/2024 | [**Viz.ai and ALCMI Partner to Unite AI and Lung Cancer Research Communities**](https://www.businesswire.com/news/siliconvalley/20240904868268/en) | [[Business Wire]] | | 9/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823031) | [[JAMA Network]] | | 9/1/2024 | [**Xtalks Announces its Life Science Webinar Calendar for September 2024**](https://www.prweb.com/releases/xtalks-announces-its-life-science-webinar-calendar-for-september-2024-302235364.html) | [[PRWeb]] | | 8/26/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2822727) | [[JAMA Network]] | | 8/12/2024 | [**Quantum Health Appoints Dr. Stanley Crittenden as New Chief Medical Officer**](http://www.businesswire.com/news/home/20240812304065/en/Quantum-Health-Appoints-Dr.-Stanley-Crittenden-as-New-Chief-Medical-Officer/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 8/12/2024 | [**Audio Highlights**](https://jamanetwork.com/journals/jama/fullarticle/2822137) | [[JAMA Network]] | | 8/5/2024 | [**Renowned surgical oncologist takes leadership role at NYU Grossman Long Island School of Medicine**](https://www.news-medical.net/news/20240805/Renowned-surgical-oncologist-takes-leadership-role-at-NYU-Grossman-Long-Island-School-of-Medicine.aspx) | [[News Medical Net]] | | 6/25/2024 | [**BioAI and Genomic Testing Cooperative Announce Strategic Collaboration to Provide AI-Powered Digital Pathology Solutions for Clinical Research and Diagnostic Applications**](https://www.prnewswire.com/news-releases/bioai-and-genomic-testing-cooperative-announce-strategic-collaboration-to-provide-ai-powered-digital-pathology-solutions-for-clinical-research-and-diagnostic-applications-302181005.html) | [[PR Newswire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Dr. Gary B. Deutsch**: Chief of the Division of Surgical Oncology at NYU Langone Hospital, specializing in robotic and minimally invasive surgeries. - **Dr. Ayana Allard-Picou**: Director of the Oncological Surgery Subdivision at Bassett Healthcare Network, recognized for her contributions to surgical oncology and patient-centered care. - **Reimagine Care**: A healthcare technology company enhancing post-operative cancer care through personalized symptom management programs. - **Ontada**: A McKesson business unit that utilizes AI to improve oncology data analysis and clinical decision-making. - **NewYork-Presbyterian**: A healthcare system investing in technologies and digital transformation in oncology and cardiology. - **Orna Therapeutics**: A company specializing in circular RNA expression technologies for innovative RNA medicines in oncology. - **Alpenglow Biosciences**: A company focused on advancing clinical product development in 3D spatial biology for precision tumor removal. - **Humana Inc.**: A health insurance company collaborating with Evolent Health to enhance prior authorization processes for surgical oncology services. - **ConcertAI**: A company focused on oncology predictive and generative AI solutions. - **NeoGenomics**: A provider of cancer-focused genetic testing services, collaborating with ConcertAI to improve clinical trial design and execution. - **Labcorp**: A global leader in laboratory services, enhancing genetic testing solutions for oncology and rare diseases. - **Azra AI**: A company providing an AI-powered oncology platform to improve patient care and operational efficiency in cancer treatment. - **Flatiron Health**: Specializes in oncology-focused electronic health record software and real-world cancer data. - **Owkin**: An AI-biotech company specializing in precision drug discovery, expanding its research capabilities in the DACH region to improve patient outcomes in various cancers. - **Massive Bio**: A company utilizing AI-driven patient matching technology to increase access to clinical trials in oncology. - **Myriad Genetics**: A company innovating in oncology and hereditary cancer testing, focusing on precision medicine. - **Texas Medical Center**: A leading healthcare institution involved in international collaborations to enhance cancer treatment and research. - **Velsera**: A global healthcare technology firm collaborating with Genoks to enhance cancer diagnostic services. - **PreciseDx**: An innovative company in oncology diagnostics utilizing AI for cancer diagnosis and prognosis. ### Partnerships and Collaborations - **Reimagine Care and health systems**: Collaborating to provide personalized, continuous care for surgical oncology patients. - **Caris Precision Oncology Alliance**: A global network of 96 cancer centers and institutions aimed at advancing precision oncology and biomarker-driven research. - **Humana and Evolent Health**: Expanded partnership to improve prior authorization processes for surgical oncology services. - **Sonrai Analytics and Massachusetts General Hospital**: Collaborating to implement AI technology for enhanced data analysis in oncology research. - **Genoks and Velsera**: Collaborating to integrate advanced genomic analysis into cancer diagnostic services. - **Alpenglow Biosciences and ARPA-H**: Secured a contract to develop a precision tumor removal platform as part of the Cancer Moonshot initiative. - **Cofactor Genomics and healthcare systems**: Implementing the OncoPrism test to enhance precision medicine solutions. - **Owkin and nine medical institutions in DACH region**: Collaboration to leverage AI technology for improving patient outcomes in prostate and bladder cancers. - **Azra AI and MultiCare Health System**: Partnership to implement an oncology platform aimed at enhancing cancer detection and treatment. - **Ontada and Microsoft**: Partnership leveraging Azure AI to process unstructured oncology documents, enhancing data extraction and analysis. - **Texas Medical Center and Mitsui Fudosan Co., Ltd.**: Signed a Memorandum of Understanding for the TMC Japan BioBridge to enhance cancer treatment through collaboration with Japanese innovators. - **University of Oxford and Apollo Therapeutics**: Collaboration to develop new therapeutics based on Oxford's biomedical research, aiming to enhance patient access to clinical trials. - **Viz.ai and Addario Lung Cancer Medical Institute**: Partnership to enhance lung cancer detection and treatment through AI technology. - **Sidekick Health and PINK!**: Acquisition of PINK! enhances Sidekick's digital therapeutics portfolio for breast cancer. - **ConcertAI and NeoGenomics**: Launched CTO-H, a software-as-a-service solution for hematological diseases, aimed at improving clinical trial design and research analytics. - **Viz.ai and ALCMI**: Collaboration to enhance lung cancer detection and treatment through AI technology. - **Labcorp and Invitae**: Partnership to leverage genetic insights for improved patient care and treatment options. - **Alpenglow Biosciences and NIH**: Awarded a contract to enhance prostate cancer diagnostics through AI-driven 3D pathology tests. - **IgniteData and Mayo Clinic**: Collaboration to implement the Archer platform for improved clinical trial data management, initially focused on oncology. - **Massive Bio and Foundation Medicine**: Strategic collaboration to improve patient access to clinical trials using AI-driven patient matching technology. ### Innovations, Trends, and Initiatives - **Surgical Robotics**: Transforming surgical procedures with precision and minimally invasive capabilities, particularly in oncology. - **Robotic Surgical Oncology Program**: Led by Dr. Deutsch at NYU Langone, focusing on enhancing cancer patients' quality of life through innovative therapies. - **3D Spatial Biology**: Alpenglow's focus on developing high-resolution 3D imaging technology to improve surgical oncology outcomes. - **AI-Powered Symptom Management**: Reimagine Care's expansion to support surgical oncology patients with AI-driven monitoring and tailored education. - **Precision Oncology**: Telix Pharmaceuticals' new business model focuses on precision medicine and theranostic solutions. - **Whole-exome sequencing (WES)**: Increasingly used in oncology for identifying genetic factors affecting diseases and guiding targeted therapies. - **3D Spatial Biology Technology**: Alpenglow's initiative to develop precision tumor removal platforms as part of the Cancer Moonshot initiative. - **Precision Medicine**: The shift towards precision medicine is being accelerated by advancements in genomics and data analytics, particularly in oncology. - **Precision Medicine Software Market**: Expected to grow significantly, driven by advancements in AI technology, particularly in oncology applications. - **AI in Oncology**: The integration of AI technologies in oncology is driving innovations in early detection, treatment planning, and patient management. - **NAVIGATE platform**: careMESH's platform integrated within EHR systems to improve patient care coordination in oncology. - **Hyper-personalized Medicine**: An emerging trend focusing on tailoring treatments based on individual genetic and environmental factors, particularly in oncology. - **Next Generation Cancer Diagnostics (NGCD)**: Utilizing liquid biopsy and genomic technologies to improve diagnostic accuracy and treatment monitoring. - **Virtual Clinical Trials**: The growing trend of decentralized clinical trials, particularly in oncology, enhancing patient access and participation. - **Theranostics Innovations by GE HealthCare**: Combining therapeutic and diagnostic technologies for a patient-centric approach to cancer care. - **CONFORM™ ONCO+**: An AI-driven accelerator launched by EDETEK Inc. to enhance efficiency and precision in oncology clinical trials. - **Digital Therapeutics**: Sidekick Health's acquisition of PINK! positions it at the forefront of digital therapeutics for cancer support. - **Project EVOLVE**: A study utilizing AI to analyze patient records for better management of serious adverse events in HER2+ breast cancer patients. ### Challenges and Concerns - **Administrative Burdens**: Challenges in prior authorization processes for surgical oncology services affecting patient access to care. - **Increasing Demand for Cancer Surgery**: Projected 52% rise by 2040, leading to potential complications and readmissions due to more complex surgeries. - **Oncology Care Model (OCM) Changes**: Concerns over the end of OCM and potential reimbursement cuts affecting community oncology practices. - **Surgical Errors and Recovery Times**: Increasing demand for surgical robots driven by the need to reduce errors and improve recovery times. - **Shortage of Oncology Professionals**: Significant lack of trained oncologists and nurses in SAARC countries due to inadequate education and training. - **Healthcare Workforce Crisis**: Projected shortfall of healthcare staff, particularly in oncology, could impact patient care and outcomes. - **Complexities of Clinical Trial Design**: The rapid evolution of treatment options in oncology requires more precise trial designs and operational efficiencies. - **Low Clinical Trial Enrollment**: Only about 8% of eligible patients currently participate in oncology clinical trials, highlighting the need for improved patient matching and access. - **Technology Overload in Community Oncology**: Community oncology practices face challenges in adopting new technologies due to limited resources, leading to fragmented systems and operational inefficiencies. - **Navigating the US Healthcare Market**: Japanese oncology companies face challenges in accessing the US market, which the TMC Japan BioBridge aims to address. - **Regulatory Compliance**: Ensuring compliance with regulations like HIPAA is critical for community oncology practices when adopting new technologies. - **Patient Recruitment for Clinical Trials**: The increasing number of therapeutic options poses challenges in patient recruitment for clinical trials, necessitating innovative solutions. - **Data Security in Precision Medicine**: Concerns regarding data security in the adoption of on-premise delivery modes for precision medicine software. - **Drug Price Negotiations**: Potential impacts on oncology providers due to the Inflation Reduction Act's drug price negotiations. - **Healthcare Staffing Issues**: Concerns regarding adequate staffing levels in hospitals, which can impact patient care and outcomes. - **Unstructured Data**: A large portion of critical patient information is found in unstructured formats, complicating data analysis and clinical decision-making. - **Regulatory Challenges**: Flatiron Health faces challenges in sales and partnerships due to ownership concerns affecting its operations. - **Data Quality and Compliance**: Ensuring high standards of data quality and compliance in clinical trials remains a significant challenge. - **Healthcare AI Adoption**: Despite significant investment, healthcare AI adoption remains low at 5%, indicating a need for transformative solutions. - **Data Privacy and Security**: Concerns regarding the adoption of AI solutions in healthcare, particularly in maintaining patient data privacy. ## Related Topics [[Oncology]]; [[Gynecologic Oncology]]; [[Ocular Oncology]]; [[Medical Oncology]]; [[Precision Oncology]]